We assigned 14 of the cancer types as ‘high LGR5 expressors’ defined by greater than 70% of component tumour biopsies as harbouring LGR5 expression levels greater than the pan-cancer median (Appendix Fig. S1A). This evidence concerns the gene LGR5 and neoplasm.